drugset / Trial / NCT00945438
Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This study is in support of the annual application for the variation of the vaccine strains for a marketing authorisation. Objectives: * To evaluate compliance, in terms of immunogenicity, of the corresponding strength of the intradermal (ID) influenza vaccine Northern Hemisphere (NH) 2009-2010 formulation. * To describe the safety of the corresponding strength of the ID influenza vaccine, NH 2009-2010 formulation.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-06
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza virus vaccine 2009-2010 formulation | Vaccine | 0.1 ml | Other |
| Subject | Influenza virus vaccine 2009-2010 formulation | Vaccine | 0.5 ml | Other |